Search Results
Showing matching global market intelligence studies.
Next Generation Sequencing Library Preparation Market
The global next generation sequencing library preparation market was valued at USD 5.1 billion in 2025 and is projected to reach USD 7.7 billion by 2033, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Next Generation Cancer Diagnostics Market
The global next generation cancer diagnostics market was valued at USD 7.3 billion in 2025 and is projected to reach USD 12.0 billion by 2033, expanding at a compound annual growth rate (CAGR) of 6.4% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Newborn Screening Market
The global newborn screening market was valued at USD 3.7 billion in 2025 and is projected to reach USD 8.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 11.6% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neurovascular Intervention Devices Market
The global neurovascular intervention devices market was valued at USD 3.9 billion in 2025 and is projected to reach USD 5.6 billion by 2033, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neurovascular Embolization Devices Market
The global neurovascular embolization devices market was valued at USD 6.1 billion in 2025 and is projected to reach USD 9.6 billion by 2033, expanding at a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neurovascular Devices Market
The global neurovascular devices market was valued at USD 5.1 billion in 2025 and is projected to reach USD 12.9 billion by 2033, expanding at a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neurovascular Catheters Market
The global neurovascular catheters market was valued at USD 4.3 billion in 2025 and is projected to reach USD 6.3 billion by 2033, expanding at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neurothrombectomy Devices Market
The global neurothrombectomy devices market was valued at USD 2.9 billion in 2025 and is projected to reach USD 6.8 billion by 2033, expanding at a compound annual growth rate (CAGR) of 11.2% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neurosurgery Surgical Power Tools Market
The global neurosurgery surgical power tools market was valued at USD 8.3 billion in 2025 and is projected to reach USD 14.2 billion by 2033, expanding at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neurostimulation Devices Market
The global neurostimulation devices market was valued at USD 6.9 billion in 2025 and is projected to reach USD 14.5 billion by 2033, expanding at a compound annual growth rate (CAGR) of 9.7% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neuroscience Market
The global neuroscience market was valued at USD 4.9 billion in 2025 and is projected to reach USD 7.4 billion by 2033, expanding at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neuroscience Antibodies Assays Market
The global neuroscience antibodies assays market was valued at USD 4.9 billion in 2025 and is projected to reach USD 12.3 billion by 2033, expanding at a compound annual growth rate (CAGR) of 12.2% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neurorehabilitation Devices Market
The global neurorehabilitation devices market was valued at USD 7.7 billion in 2025 and is projected to reach USD 16.6 billion by 2033, expanding at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neuromodulation Devices Market
The global neuromodulation devices market was valued at USD 5.1 billion in 2025 and is projected to reach USD 10.0 billion by 2033, expanding at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.
Neurometabolic Disorders Market
The global neurometabolic disorders market was valued at USD 4.5 billion in 2025 and is projected to reach USD 8.6 billion by 2033, expanding at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033. North America and Asia Pacific represent key revenue pockets due to increasing industrial adoption and rising infrastructure investments.